{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T15:39:14Z","timestamp":1780760354885,"version":"3.54.1"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,11,16]],"date-time":"2018-11-16T00:00:00Z","timestamp":1542326400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2018,11,16]],"date-time":"2018-11-16T00:00:00Z","timestamp":1542326400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004327","name":"SingHealth Foundation","doi-asserted-by":"publisher","award":["SHF\/FG541P\/2013"],"award-info":[{"award-number":["SHF\/FG541P\/2013"]}],"id":[{"id":"10.13039\/501100004327","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004327","name":"SingHealth Foundation","doi-asserted-by":"publisher","award":["SHF\/FG541P\/2013"],"award-info":[{"award-number":["SHF\/FG541P\/2013"]}],"id":[{"id":"10.13039\/501100004327","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>There are no reliable biomarkers to predict thyroid eye disease (TED) in patients with autoimmune thyroid disease (AITD) currently. Several evidences support the involvement of the lacrimal gland in TED. The aim of our study was to quantitatively correlate the changes in tear protein profile with increasing severity of TED. Tear samples were collected from four groups of patients; AITD without TED\u00a0(AITD), AITD with\u00a0mild TED\u00a0(mild TED), AITD with\u00a0severe TED\u00a0(severe TED) and normal controls. A total of 72 patients were recruited for the study. In discovery phase, isobaric tags for relative and absolute quantification (iTRAQ) 4-plex was used for quantitative proteomics analysis. For verification of results from discovery phase, sequential window acquisition of all theoretical fragment ion spectra (SWATH) was used to analyze an independent cohort from normal\u00a0controls, AITD, mild TED and severe TED. Two proteins, S100A4 and PIP showed consistent dysregulation trends in the discovery and validation phase experiments. Our study demonstrated the differences in tear proteome across the spectrum of different severity and activity of TED in patients with AITD. Two tear proteins, S100A4 and PIP may serve as potential biomarkers to predict progression to severe TED in patients with AITD.<\/jats:p>","DOI":"10.1038\/s41598-018-35096-x","type":"journal-article","created":{"date-parts":[[2018,11,12]],"date-time":"2018-11-12T13:02:27Z","timestamp":1542027747000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["Tear Proteins Calcium binding protein A4 (S100A4) and Prolactin Induced Protein (PIP) are Potential Biomarkers for Thyroid Eye Disease"],"prefix":"10.1038","volume":"8","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2232-5298","authenticated-orcid":false,"given":"Chiaw-Ling","family":"Chng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lay Leng","family":"Seah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morgan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunny Yu","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siew Kwan","family":"Koh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louis","family":"Tong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger Wilmer","family":"Beuerman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,11,16]]},"reference":[{"key":"35096_CR1","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1007\/s40618-014-0097-2","volume":"37","author":"L Bartalena","year":"2014","unstructured":"Bartalena, L. & Fatourechi, V. Extrathyroidal manifestations of Graves\u2019 disease: A 2014 update. Journal of Endocrinological Investigation 37, 691\u2013700 (2014).","journal-title":"Journal of Endocrinological Investigation"},{"key":"35096_CR2","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1159\/000443828","volume":"5","author":"L Bartalena","year":"2016","unstructured":"Bartalena, L. et al. The 2016 European Thyroid Association\/European Group on Graves\u2019 orbitopathy guidelines for the management of graves\u2019 orbitopathy. Eur. Thyroid J. 5, 9\u201326 (2016).","journal-title":"Eur. Thyroid J."},{"key":"35096_CR3","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.exer.2013.07.015","volume":"117","author":"N von Thun und Hohenstein-Blaul","year":"2013","unstructured":"von Thun und Hohenstein-Blaul, N., Funke, S. & Grus, F. H. Tears as a source of biomarkers for ocular and systemic diseases. Experimental Eye Research 117, 126\u2013137 (2013).","journal-title":"Experimental Eye Research"},{"issue":"8","key":"35096_CR4","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1038\/sj.eye.6700566","volume":"17","author":"J M Tiffany","year":"2003","unstructured":"Tiffany, J. M. Tears in health and disease. Eye Lond. Engl. https:\/\/doi.org\/10.1038\/sj.eye.6700566 (2003).","journal-title":"Eye"},{"key":"35096_CR5","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1016\/j.preteyeres.2012.06.002","volume":"31","author":"L Zhou","year":"2012","unstructured":"Zhou, L. & Beuerman, R. W. Tear analysis in ocular surface diseases. Progress in Retinal and Eye Research 31, 527\u2013550 (2012).","journal-title":"Progress in Retinal and Eye Research"},{"key":"35096_CR6","doi-asserted-by":"publisher","first-page":"4889","DOI":"10.1021\/pr900686s","volume":"8","author":"L Zhou","year":"2009","unstructured":"Zhou, L. et al. Identification of Tear Fluid Biomarkers in Dry Eye Syndrome Using iTRAQ Quantitative Proteomics. J. Proteome Res. 8, 4889\u20134905 (2009).","journal-title":"J. Proteome Res."},{"key":"35096_CR7","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1038\/eye.2011.105","volume":"25","author":"A Acera","year":"2011","unstructured":"Acera, A. et al. Changes in tear protein profile in keratoconus disease. Eye 25, 1225\u20131233 (2011).","journal-title":"Eye"},{"key":"35096_CR8","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1039\/c3mb25463a","volume":"9","author":"D Pieragostino","year":"2013","unstructured":"Pieragostino, D. et al. Shotgun proteomics reveals specific modulated protein patterns in tears of patients with primary open angle glaucoma na\u00efve to therapy. Mol. Biosyst. 9, 1108 (2013).","journal-title":"Mol. Biosyst."},{"key":"35096_CR9","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1111\/j.1395-3907.2004.00268.x","volume":"82","author":"AK Eckstein","year":"2004","unstructured":"Eckstein, A. K. et al. Dry eye syndrome in thyroid-associated ophthalmo- pathy: lacrimal expression of TSH receptor suggests involvement of TSHR-specific autoantibodies. Acta Ophthalmol. Scand. 82, 291\u2013297 (2004).","journal-title":"Acta Ophthalmol. Scand."},{"key":"35096_CR10","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1016\/S0161-6420(81)34993-8","volume":"88","author":"SL Trokel","year":"1981","unstructured":"Trokel, S. L. & Jakobiec, F. A. Correlation of CT Scanning and Pathologic Features of Ophthalmic Graves\u2019 Disease. Ophthalmology 88, 553\u2013564 (1981).","journal-title":"Ophthalmology"},{"key":"35096_CR11","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1111\/j.1365-2265.1990.tb00897.x","volume":"32","author":"TC Chang","year":"1990","unstructured":"Chang, T. C., Huang, K. M., Chang, T. J. & Lin, S. L. Correlation of orbital computed tomography and antibodies in patients with hyperthyroid Graves\u2019DISEASE. Clin. Endocrinol. (Oxf.) 32, 551\u2013558 (1990).","journal-title":"Clin. Endocrinol. (Oxf.)"},{"key":"35096_CR12","doi-asserted-by":"publisher","first-page":"4935","DOI":"10.1167\/iovs.13-13704","volume":"55","author":"D Huang","year":"2014","unstructured":"Huang, D., Luo, Q., Yang, H. & Mao, Y. Changes of lacrimal gland and tear inflammatory cytokines in thyroid-associated ophthalmopathy. Invest. Ophthalmol. Vis. Sci. 55, 4935\u20134943 (2014).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"35096_CR13","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1016\/S0161-6420(96)30579-4","volume":"103","author":"GB Bartley","year":"1996","unstructured":"Bartley, G. B. & Gorman, C. A. Diagnostic criteria for Graves\u2019 ophthalmopathy. Am. J. Ophthalmol. 119, 792\u2013795 (1995).","journal-title":"Ophthalmology"},{"key":"35096_CR14","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.beem.2011.11.007","volume":"26","author":"PJ Dolman","year":"2012","unstructured":"Dolman, P. J. Evaluating Graves\u2019 Orbitopathy. Best Practice and Research: Clinical Endocrinology and Metabolism 26, 229\u2013248 (2012).","journal-title":"Best Practice and Research: Clinical Endocrinology and Metabolism"},{"issue":"Suppl 1","key":"35096_CR15","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1097\/01.icu.0000512373.81749.b7","volume":"27","author":"MS Milner","year":"2017","unstructured":"Milner, M. S. et al. Dysfunctional tear syndrome: dry eye disease and associated tear film disorders - new strategies for diagnosis and treatment. Curr. Opin. Ophthalmol. 27(Suppl 1), 3\u201347 (2017).","journal-title":"Curr. Opin. Ophthalmol."},{"key":"35096_CR16","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1089\/thy.2012.0119","volume":"22","author":"N Matheis","year":"2012","unstructured":"Matheis, N., Okrojek, R., Grus, F. H. & Kahaly, G. J. Proteomics of Tear Fluid in Thyroid-Associated Orbitopathy. Thyroid 22, 1039\u20131045 (2012).","journal-title":"Thyroid"},{"key":"35096_CR17","doi-asserted-by":"crossref","first-page":"4493","DOI":"10.3760\/cma.j.issn.0366-6999.20131644","volume":"126","author":"LH Jiang","year":"2013","unstructured":"Jiang, L. H. & Wei, R. L. Analysis of Graves\u2019 ophthalmopathy patients\u2019 tear protein spectrum. Chin. Med. J. (Engl.) 126, 4493\u20134498 (2013).","journal-title":"Chin. Med. J. (Engl.)"},{"key":"35096_CR18","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1055\/s-0029-1214413","volume":"41","author":"R Okrojek","year":"2009","unstructured":"Okrojek, R., Grus, F. H., Matheis, N. & Kahaly, G. J. Proteomics in autoimmune thyroid eye disease. Horm. Metab. Res. Horm. Stoffwechselforschung Horm. Mtabolisme 41, 465\u2013470 (2009).","journal-title":"Horm. Metab. Res. Horm. Stoffwechselforschung Horm. Mtabolisme"},{"key":"35096_CR19","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1111\/cen.13122","volume":"85","author":"C Aass","year":"2016","unstructured":"Aass, C. et al. Comparative proteomic analysis of tear fluid in Graves\u2019 disease with and without orbitopathy. Clin. Endocrinol. (Oxf.) 85, 805\u2013812 (2016).","journal-title":"Clin. Endocrinol. (Oxf.)"},{"key":"35096_CR20","doi-asserted-by":"publisher","first-page":"2649","DOI":"10.1167\/iovs.15-16699","volume":"56","author":"N Matheis","year":"2015","unstructured":"Matheis, N. et al. Proteomics Differentiate Between Thyroid-Associated Orbitopathy and Dry Eye Syndrome. Invest. Ophthalmol. Vis. Sci. 56, 2649\u20132656 (2015).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"35096_CR21","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1001\/archopht.124.10.1451","volume":"124","author":"GRC Baker","year":"2006","unstructured":"Baker, G. R. C. et al. Altered tear composition in smokers and patients with graves ophthalmopathy. Arch. Ophthalmol. 124, 1451\u20136 (2006).","journal-title":"Arch. Ophthalmol."},{"key":"35096_CR22","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1021\/acs.jproteome.6b00805","volume":"16","author":"WM Nadler","year":"2017","unstructured":"Nadler, W. M. et al. MALDI versus ESI: The Impact of the Ion Source on Peptide Identification. J. Proteome Res. 16, 1207\u20131215 (2017).","journal-title":"J. Proteome Res."},{"key":"35096_CR23","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1167\/iovs.04-0448","volume":"46","author":"FH Grus","year":"2005","unstructured":"Grus, F. H. et al. SELDI-TOF-MS ProteinChip array profiling of tears from patients with dry eye. Invest. Ophthalmol. Vis. Sci. 46, 863\u2013876 (2005).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"10","key":"35096_CR24","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1080\/14789450.2016.1229601","volume":"13","author":"Stefani N. Thomas","year":"2016","unstructured":"Thomas, S. N. & Zhang, H. Targeted proteomic assays for the verification of global proteomics insights. Expert Rev. Proteomics 1\u20133 https:\/\/doi.org\/10.1080\/14789450.2016.1229601 (2016).","journal-title":"Expert Review of Proteomics"},{"key":"35096_CR25","doi-asserted-by":"publisher","first-page":"3793","DOI":"10.1021\/acs.jproteome.5b00438","volume":"14","author":"G Hou","year":"2015","unstructured":"Hou, G. et al. Biomarker Discovery and Verification of Esophageal Squamous Cell Carcinoma Using Integration of SWATH\/MRM. J. Proteome Res. 14, 3793\u20133803 (2015).","journal-title":"J. Proteome Res."},{"issue":"5","key":"35096_CR26","doi-asserted-by":"publisher","first-page":"e0125934","DOI":"10.1371\/journal.pone.0125934","volume":"10","author":"Sylvie Bourassa","year":"2015","unstructured":"Bourassa, S. et al. Evaluation of iTRAQ and SWATH-MS for the quantification of proteins associated with insulin resistance in human duodenal biopsy samples. PLoS ONE 10, (2015).","journal-title":"PLOS ONE"},{"key":"35096_CR27","first-page":"d1356","volume":"7","author":"CW Heizmann","year":"2002","unstructured":"Heizmann, C. W., Fritz, G. & Sch\u00e4fer, B. W. S100 proteins: structure, functions and pathology. Front. Biosci. J. Virtual Libr. 7, d1356\u2013d1368 (2002).","journal-title":"Front. Biosci. J. Virtual Libr."},{"key":"35096_CR28","doi-asserted-by":"publisher","first-page":"492","DOI":"10.2174\/156652408785747942","volume":"8","author":"M Grigorian","year":"2008","unstructured":"Grigorian, M., Ambartsumian, N. & Lukanidin, E. Metastasis-inducing S100A4 protein: implication in non-malignant human pathologies. Curr. Mol. Med. 8, 492\u2013496 (2008).","journal-title":"Curr. Mol. Med."},{"key":"35096_CR29","doi-asserted-by":"publisher","first-page":"2077","DOI":"10.1167\/iovs.08-2604","volume":"50","author":"L Zhou","year":"2009","unstructured":"Zhou, L. et al. Elevation of human \u03b1-defensins and s100 calcium-binding proteins A8 and A9 in tear fluid of patients with pterygium. Invest. Ophthalmol. Vis. Sci. 50, 2077\u20132086 (2009).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"35096_CR30","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1007\/s00417-010-1456-0","volume":"249","author":"C Kramann","year":"2011","unstructured":"Kramann, C. et al. Effect of contact lenses on the protein composition in tear film: A ProteinChip study. Graefes Arch. Clin. Exp. Ophthalmol. 249, 233\u2013243 (2011).","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"35096_CR31","first-page":"2263","volume":"17","author":"J Li","year":"2011","unstructured":"Li, J. et al. S100A expression in normal corneal-limbal epithelial cells and ocular surface squamous cell carcinoma tissue. Mol. Vis. 17, 2263\u201371 (2011).","journal-title":"Mol. Vis."},{"key":"35096_CR32","first-page":"146","volume":"19","author":"M Nubile","year":"2013","unstructured":"Nubile, M. et al. S100 A and B expression in normal and inflamed human limbus. Mol. Vis. 19, 146\u201352 (2013).","journal-title":"Mol. Vis."},{"key":"35096_CR33","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1136\/bjo.2004.049742","volume":"89","author":"HS Dua","year":"2005","unstructured":"Dua, H. S. Limbal epithelial crypts: a novel anatomical structure and a putative limbal stem cell niche. Br. J. Ophthalmol. 89, 529\u2013532 (2005).","journal-title":"Br. J. Ophthalmol."},{"key":"35096_CR34","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1038\/eye.1989.26","volume":"3","author":"JD Nelson","year":"1989","unstructured":"Nelson, J. D. Superior limbic keratoconjunctivitis (SLK). Eye Basingstoke 3, 180\u2013189 (1989).","journal-title":"Eye Basingstoke"},{"key":"35096_CR35","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1046\/j.1442-9071.2000.00284.x","volume":"28","author":"I Cher","year":"2000","unstructured":"Cher, I. Superior limbic keratoconjunctivitis: Multifactorial mechanical pathogenesis. In Clinical and Experimental Ophthalmology 28, 181\u2013184 (2000).","journal-title":"Clinical and Experimental Ophthalmology"},{"key":"35096_CR36","doi-asserted-by":"publisher","first-page":"1472","DOI":"10.1016\/S0161-6420(95)30843-3","volume":"102","author":"EF Kadrmas","year":"1995","unstructured":"Kadrmas, E. F. & Bartley, G. B. Superior Limbic Keratoconjunctivitis: A Prognostic Sign for Severe Graves Ophthalmopathy. Ophthalmology 102, 1472\u20131475 (1995).","journal-title":"Ophthalmology"},{"key":"35096_CR37","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.jtos.2013.10.001","volume":"12","author":"L Tong","year":"2014","unstructured":"Tong, L., Lan, D. W., Lim, R. R. & Chaurasia, S. S. S100A Proteins as Molecular Targets in the Ocular Surface Inflammatory Diseases. Ocul. Surf. 12, 23\u201331 (2014).","journal-title":"Ocul. Surf."},{"key":"35096_CR38","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1007\/978-3-319-12114-7_8","volume":"846","author":"A Naderi","year":"2015","unstructured":"Naderi, A. Prolactin-Induced Protein in Breast Cancer. Adv. Exp. Med. Biol. 846, 189\u2013200 (2015).","journal-title":"Adv. Exp. Med. Biol."},{"key":"35096_CR39","doi-asserted-by":"publisher","DOI":"10.1016\/j.preteyeres.2018.05.002","author":"R Sharif","year":"2018","unstructured":"Sharif, R., Bak-Nielsen, S., Hjortdal, J. & Karamichos, D. Pathogenesis of Keratoconus: The intriguing therapeutic potential of Prolactin-inducible protein. Prog. Retin. Eye Res. https:\/\/doi.org\/10.1016\/j.preteyeres.2018.05.002 (2018).","journal-title":"Prog. Retin. Eye Res."},{"key":"35096_CR40","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1089\/dna.2016.3472","volume":"35","author":"OC Ihedioha","year":"2016","unstructured":"Ihedioha, O. C., Shiu, R. P. C., Uzonna, J. E. & Myal, Y. Prolactin-Inducible Protein: From Breast Cancer Biomarker to Immune Modulator\u2014Novel Insights from Knockout Mice. DNA Cell Biol. 35, 537\u2013541 (2016).","journal-title":"DNA Cell Biol."},{"key":"35096_CR41","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1089\/thy.2007.0405","volume":"18","author":"AG Gianoukakis","year":"2008","unstructured":"Gianoukakis, A. G., Khadavi, N. & Smith, T. J. Cytokines, Graves\u2019 disease, and thyroid-associated ophthalmopathy. Thyroid Off. J. Am. Thyroid Assoc. 18, 953\u2013958 (2008).","journal-title":"Thyroid Off. J. Am. Thyroid Assoc."},{"key":"35096_CR42","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.exer.2018.10.015","volume":"179","author":"Rabab Sharif","year":"2019","unstructured":"Sharif, R. et al. Prolactin-Induced Protein is a novel biomarker for Keratoconus. Exp. Eye Res. https:\/\/doi.org\/10.1016\/j.exer.2018.10.015 (2018).","journal-title":"Experimental Eye Research"},{"issue":"11","key":"35096_CR43","doi-asserted-by":"publisher","first-page":"e113310","DOI":"10.1371\/journal.pone.0113310","volume":"9","author":"Shrestha Priyadarsini","year":"2014","unstructured":"Priyadarsini, S. et al. Gross cystic disease fluid protein-15\/prolactin-inducible protein as a biomarker for keratoconus disease. PLoS ONE 9, (2014).","journal-title":"PLoS ONE"},{"key":"35096_CR44","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1056\/NEJMra0905750","volume":"362","author":"RS Bahn","year":"2010","unstructured":"Bahn, R. S. Graves\u2019 Ophthalmopathy. N Engl J Med 362, 726\u2013738 (2010).","journal-title":"N Engl J Med"},{"key":"35096_CR45","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1210\/jcem.87.1.8164","volume":"87","author":"TJ Smith","year":"2002","unstructured":"Smith, T. J. et al. Orbital fibroblast heterogeneity may determine the clinical presentation of thyroid-associated ophthalmopathy. J. Clin. Endocrinol. Metab. 87, 385\u2013392 (2002).","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"6","key":"35096_CR46","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1016\/S0161-6420(96)30579-4","volume":"103","author":"George B. Bartley","year":"1996","unstructured":"Bartley, G. B. et al. Long-term follow-up of Graves ophthalmopathy in an incidence cohort. Ophthalmology 103, 958\u2013962 (1996).","journal-title":"Ophthalmology"},{"key":"35096_CR47","first-page":"479","volume":"107","author":"M Nowak","year":"2005","unstructured":"Nowak, M., Marek, B., Kos-Kud\u0142a, B., Kajdaniuk, D. & Siemi\u0144ska, L. Tear film profile in patients with active thyroid orbithopathy. Klin. Oczna 107, 479\u201382 (2005).","journal-title":"Klin. Oczna"},{"key":"35096_CR48","first-page":"57","volume":"9","author":"JH Selter","year":"2015","unstructured":"Selter, J. H., Gire, A. I. & Sikder, S. The relationship between Graves\u2019 ophthalmopathy and dry eye syndrome. Clin. Ophthalmol. Auckl. NZ 9, 57\u201362 (2015).","journal-title":"Clin. Ophthalmol. Auckl. NZ"},{"key":"35096_CR49","doi-asserted-by":"publisher","first-page":"8","DOI":"10.3109\/02713683.2010.526285","volume":"36","author":"C G\u00fcrdal","year":"2011","unstructured":"G\u00fcrdal, C. et al. Ocular surface and dry eye in Graves\u2019 disease. Curr. Eye Res. 36, 8\u201313 (2011).","journal-title":"Curr. Eye Res."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-35096-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-35096-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-35096-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,12]],"date-time":"2024-07-12T08:45:03Z","timestamp":1720773903000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-35096-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11,16]]},"references-count":49,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,12]]}},"alternative-id":["35096"],"URL":"https:\/\/doi.org\/10.1038\/s41598-018-35096-x","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11,16]]},"assertion":[{"value":"24 July 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 October 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 November 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"16936"}}